Skip to content
CompanySight
Company No. 03393503 · Incorporated 27 Jun 1997

Bristol Laboratories Limited

Registered name: BRISTOL LABORATORIES LIMITED

Part of Bristol Laboratories Group Limited group

Bristol Laboratories Limited made £37m revenue and a £15.8m loss in the year to 31 Mar 2025. read from filing text

Bristol Laboratories Limited’s revenue fell 45% to £37m in the year to 31 Mar 2025, with a loss of £15.8m and 472 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Berkhamsted; we hold 3 years of its filed accounts.

Status
Active
Location
Berkhamsted, South East
Age
29 yrs · since 1997
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company is a 100% subsidiary of Bristol Laboratories Group Ltd, a company incorporated in England.”

Latest accounts · year to 31 Mar 2025

Key figures

Cash flow filed
Revenue
£37m
Growth ▼44.6%
Profit
−£15.8m
Growth ▼1933%
Profit margin
−42.6%
Gross −30.6%
Employees
472
Change ▼11.1%
Profit / employee
−£33.4k
Revenue/employee £78.4k
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Mar 202331 Mar 202431 Mar 2025
DisclosureFull P&Lread from filing textFull P&Lread from filing textFull P&Lread from filing text
Profit & loss
Revenue (turnover)£70m£66.8m£37m
Cost of sales£57.8m£56.7m£48.3m
Gross profit£12.3m£10.1m−£11.3m
Operating profit£6.2m£1.8m−£20.5m
Profit before tax£5.5m£900k−£15.3m
Profit after tax£6m£861k−£15.8m
Profit (best available)£6m£861k−£15.8m
Staff costs£18.2m£19.6m£16.8m
Employees (average)477531472
Ratios
Profit margin8.5%1.3%−42.6%
Gross margin17.5%15.1%−30.6%
Revenue per employee£147k£126k£78.4k
Profit per employee£12.5k£1.6k−£33.4k
Cash conversion31.7%−419.5%—
Growth (year on year)
Revenue growth—▼4.6%▼44.6%
Profit growth—▼85.6%▼1933%
Headcount growth—▲11.3%▼11.1%
Balance sheet — indirect signals, not revenue
Cash at bank£450k£516k£97.3k
Net assets£27.7m£29.1m£13.7m
Fixed assets£26.1m£26.2m£25.3m
Current assets£46.8m£41.1m£29.3m
Debtors£16.9m£12.3m£8.6m
Deferred income£1.1m£1m£581k
Cash from operations£2m−£7.7m£6.1m
SourceFullAccounts · bulk data Mar 2025FullAccounts · bulk data Mar 2025FullAccounts · bulk data Jun 2026
Derived from the latest filing

How the business works

Profit margin
−42.6%
Profit ÷ revenue.
Gross margin
−30.6%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£78.4k
Revenue ÷ average employees.
Profit per employee
−£33.4k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
68.3%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
1.6%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
23.3%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▼53%
Now £13.7m
Cash at bank
▼81%
Now £97.3k
Headcount
▼11%
Now 472
Deferred income
▼43%
Now £581k
Fixed assets
▼3%
Now £25.3m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Bristol Laboratories Group Limitedultimate parent75–100%
  2. Bristol Laboratories Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£15.8m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.